Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes

Abstract

Later initiation of bDMARDs in JIA is associated with a greater physical disability, worse HRQoL, and lower chance of drug-free remission in adulthood.